Drug price increases saw ‘high water mark’ year in 2015: Analysts

Emily Wasserman

hikes have landed pharma in hot lately, with lawmakers, the public and presidential hopefuls lashing out at companies over skyrocketing costs. But things could calm down a bit in the new , according to some , who see for branded drugs tapering off in 2016.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS